TB Road map and action plan to be launched in Moscow
The new Road map and action plan to prevent and combat drug resistant TB in the European Region will be launched 10 October 2011, at the International MDG-6 Forum, in Moscow, Russian Federation, where donors, international agencies and health decision-makers from Europe will discuss accelerated action to reach the Millennium Development Goal 6.
Ms Zsuzsanna Jakab, WHO Regional Director for Europe will launch the Road map with key stakeholders including Professor Michel Kazatchkine, the Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria and Dr Lucica Ditiu, Executive Secretary of StopTB partnership followed by question and answer sessions.
Multidrug- and extensively drug-resistant tuberculosis (M/XDR-TB) is the result of inadequate treatment of tuberculosis and poor airborne infection control. Of the 27 countries worldwide with a high burden of MDR-TB, 15 are in the Region. Recent surveys indicate that in some settings up to 40% of new TB patients and up to 70% of previously treated patients may have drug resistant TB. From an estimated 81 000 MDR-TB patients in the Region, only one third are notified due to limited laboratory capacity and only two thirds of these are reported as receiving adequate treatment. If the new Road map is followed, it is calculated that interrupting the spread of MDR/TB would save 120 000 lives and save US$ 12 billion. The Road map helps countries to implement the new Consolidated Action Plan to Prevent and Combat Drug Resistant TB in the European Region, which was developed by WHO/Europe in consultation with Member States, stakeholders and communities
The Road map was developed by WHO/Europe in consultation with Member States, stakeholders and communities and was endorsed by the WHO Regional Committee for Europe at its sixty-first session in Baku, Azerbaijan, on 15 September 2011.